The landscape and therapeutic relevance of cancer-associated transcript fusions (original) (raw)

• Mitelman F, Johansson B, Mertens F . The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7: 233–245.
  Article CAS Google Scholar
• Nowell PC, Hungerford DA . A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1488–1501.
  Article Google Scholar
• Kantarjian H, Shah NP, Hochhaus A, Cortes J, Shah S, Ayala M et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010; 362: 2260–2270.
  Article CAS Google Scholar
• Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561–566.
  Article CAS Google Scholar
• Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 2013; 368: 2385–2394.
  Article CAS Google Scholar
• Meyerson M, Gabriel S, Getz G . Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010; 11: 685–696.
  Article CAS Google Scholar
• Watson IR, Takahashi K, Futreal PA, Chin L . Emerging patterns of somatic mutations in cancer. Nat Rev Genet 2013; 14: 703–718.
  Article CAS Google Scholar
• Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 2012; 337: 1231–1235.
  Article CAS Google Scholar
• Guo G, Sun X, Chen C, Wu S, Huang P, Li Z et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 2013; 45: 1459–1463.
  Article CAS Google Scholar
• Wu YM, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, Cao X et al. Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov 2013; 3: 636–647.
  Article CAS Google Scholar
• Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y et al. C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 2014; 506: 451–455.
  Article CAS Google Scholar
• Honeyman JN, Simon EP, Robine N, Chiaroni-Clarke R, Darcy DG, Lim II et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 2014; 343: 1010–1014.
  Article CAS Google Scholar
• Shah N, Lankerovich M, Lee H, Yoon JG, Schroeder B, Foltz G . Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data. BMC Genomics 2013; 14: 818.
  Article CAS Google Scholar
• Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov 2014; 4: 216–231.
  Article CAS Google Scholar
• Seo JS, Ju YS, Lee WC, Shin JY, Lee JK, Bleazard T et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 2012; 22: 2109–2119.
  Article CAS Google Scholar
• Wu C, Wyatt AW, Lapuk AV, McPherson A, McConeghy BJ, Bell RH et al. Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer. J Pathol 2012; 227: 53–61.
  Article CAS Google Scholar
• Torres-Garcia W, Zheng S, Sivachenko A, Vegesna R, Wang Q, Yao R et al. PRADA: Pipeline for RNA sequencing Data Analysis. Bioinformatics 2014; 30: 2224–2226.
  Article CAS Google Scholar
• Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, Pohl CS et al. BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 2009; 6: 677–681.
  Article CAS Google Scholar
• Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013; 45: 1134–1140.
  Article CAS Google Scholar
• Kalyana-Sundaram S, Shankar S, Deroo S, Iyer MK, Palanisamy N, Chinnaiyan AM et al. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer. Neoplasia 2012; 14: 702–708.
  Article CAS Google Scholar
• Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K et al. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 2011; 12: R6.
  Article CAS Google Scholar
• Kim P, Yoon S, Kim N, Lee S, Ko M, Lee H et al. ChimerDB 2.0—a knowledgebase for fusion genes updated. Nucleic Acids Res 2010; 38: D81–D85.
  Article CAS Google Scholar
• Mitelman F, Johansson B, Mertens F . Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 2004; 36: 331–334.
  Article CAS Google Scholar
• Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644–648.
  Article CAS Google Scholar
• The Cancer Genome Atlas Research N. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N Engl J Med 2013; 368: 2059–2074.
  Article Google Scholar
• Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W et al. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes Dev 2013; 27: 1462–1472.
  Article CAS Google Scholar
• Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR et al. The somatic genomic landscape of glioblastoma. Cell 2013; 155: 462–477.
  Article CAS Google Scholar
• Shaw AT, Hsu PP, Awad MM, Engelman JA . Tyrosine kinase gene rearrangements in epithelial malignancies. Nat Rev Cancer 2013; 13: 772–787.
  Article CAS Google Scholar
• Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med 2012; 367: 1694–1703.
  Article CAS Google Scholar
• Vaishnavi A, Capelletti M, Le AT, Kako S, Butaney M, Ercan D et al. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 2013; 19: 1469–1472.
  Article CAS Google Scholar
• Wells SA Jr, Gosnell JE, Gagel RF, Moley J, Pfister D, Sosa JA et al. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol 2010; 28: 767–772.
  Article CAS Google Scholar
• Lam ET, Ringel MD, Kloos RT, Prior TW, Knopp MV, Liang J et al. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol 2010; 28: 2323–2330.
  Article CAS Google Scholar
• Hallberg B, Palmer RH . Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer 2013; 13: 685–700.
  Article CAS Google Scholar
• Hojfeldt JW, Agger K, Helin K . Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov 2013; 12: 917–930.
  Article CAS Google Scholar
• Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M . Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012; 11: 384–400.
  Article CAS Google Scholar
• Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006; 106: 1794–1803.
  Article CAS Google Scholar
• Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S et al. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol 2007; 25: 3109–3115.
  Article CAS Google Scholar
• Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 2011; 20: 53–65.
  Article CAS Google Scholar
• Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, Chan MY et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res 2013; 73: 4711–4721.
  Article CAS Google Scholar
• Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499: 214–218.
  Article CAS Google Scholar
• Asmann YW, Hossain A, Necela BM, Middha S, Kalari KR, Sun Z et al. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 2011; 39: e100.
  Article CAS Google Scholar
• Gough SM, Lee F, Yang F, Walker RL, Zhu YJ, Pineda M et al. NUP98-PHF23 is a chromatin modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD domain histone reader function. Cancer Discov 2014; 4: 564–577.
  Article CAS Google Scholar
• Cadot B, Brunetti M, Coppari S, Fedeli S, de Rinaldis E, Dello Russo C et al. Loss of histone deacetylase 4 causes segregation defects during mitosis of p53-deficient human tumor cells. Cancer Res 2009; 69: 6074–6082.
  Article CAS Google Scholar
• Tusher VG, Tibshirani R, Chu G . Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121.
  Article CAS Google Scholar
• Li H, Durbin R . Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26: 589–595.
  Article Google Scholar
• McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297–1303.
  Article CAS Google Scholar
• Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078–2079.
  Article Google Scholar
• Cancer Genome Atlas Research N. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499: 43–49.
  Article Google Scholar
• Zhao M, Sun J, Zhao Z . TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res 2013; 41: D970–D976.
  Article CAS Google Scholar
• Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al. A census of human cancer genes. Nat Rev Cancer 2004; 4: 177–183.
  Article CAS Google Scholar
• Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G . GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 2011; 12: R41.
  Article Google Scholar
• Li J, Lu Y, Akbani R, Ju Z, Roebuck PL, Liu W et al. TCPA: a resource for cancer functional proteomics data. Nat Methods 2013; 10: 1046–1047.
  Article CAS Google Scholar
• R Core Team R: A language and environment for statistical computing 2013.